India, Oct. 28 -- The National Pharmaceutical Pricing Authority (NPPA) has revised the maximum retail prices (MRPs) of 543 brands of anti-cancer medicines, with the new rates set to come into effect on November 9. Some medicines have seen price reductions of up to 90%, potentially offering significant relief to cancer patients.

The revised list, seen by HT, includes price information submitted by pharmaceutical companies up to October 27, the authority said. It covers different brands, strengths and pack sizes, and will be updated as manufacturers submit further information.

Among the medicines seeing steep price cuts is RPG Life Sciences' Anarzole, a 1 mg anastrozole tablet used to treat hormone-sensitive breast cancer. The price of a ...